| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2021-02-12 | STATE STREET CORP | JOHNSON & JOHNSON | - | 5.5% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | JOHNSON & JOHNSON | 227,946,104 | 8.7% | EDGAR |
| SC 13G/A | 2021-02-02 | JOHNSON & JOHNSON | Protagonist Therapeutics, Inc | 2,449,183 | 5.7% | EDGAR |
| SC 13G/A | 2021-01-29 | BlackRock Inc. | JOHNSON & JOHNSON | 188,510,542 | 7.2% | EDGAR |
| SC 13G | 2020-07-06 | JOHNSON & JOHNSON | Fusion Pharmaceuticals Inc. | 3,759,634 | 9.0% | EDGAR |
| SC 13G | 2020-02-13 | STATE STREET CORP | JOHNSON & JOHNSON | - | 5.8% | EDGAR |
| SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | JOHNSON & JOHNSON | 228,297,775 | 8.7% | EDGAR |
| SC 13G/A | 2020-02-10 | BlackRock Inc. | JOHNSON & JOHNSON | 193,071,388 | 7.3% | EDGAR |
| SC 13G/A | 2020-01-17 | JOHNSON & JOHNSON | Provention Bio, Inc. | 1,124,973 | 2.4% | EDGAR |
| SC 13G/A | 2020-01-17 | JOHNSON & JOHNSON | PhaseBio Pharmaceuticals Inc | 1,607,044 | 5.6% | EDGAR |
| SC 13G | 2019-11-26 | JOHNSON & JOHNSON | BiomX Inc. | 2,133,402 | 9.3% | EDGAR |
| SC 13G | 2019-03-04 | JOHNSON & JOHNSON | MeiraGTx Holdings plc | 2,898,550 | 8.7% | EDGAR |
| SC 13G | 2019-02-13 | STATE STREET CORP | JOHNSON & JOHNSON | - | 5.7% | EDGAR |
| SC 13G/A | 2019-02-11 | BlackRock Inc. | JOHNSON & JOHNSON | 183,775,823 | 6.9% | EDGAR |
| SC 13G/A | 2019-02-11 | VANGUARD GROUP INC | JOHNSON & JOHNSON | 221,324,574 | 8.2% | EDGAR |
| SC 13G/A | 2019-01-22 | JOHNSON & JOHNSON | GI DYNAMICS, INC. | 565,569 | 3.7% | EDGAR |
| SC 13G/A | 2019-01-22 | JOHNSON & JOHNSON | Aldeyra Therapeutics, Inc. | 1,050,292 | 4.0% | EDGAR |
| SC 13G/A | 2019-01-22 | JOHNSON & JOHNSON | ADURO BIOTECH, INC. | 3,906,207 | 4.9% | EDGAR |
| SC 13G/A | 2019-01-22 | JOHNSON & JOHNSON | MACROGENICS INC | 1,923,077 | 4.6% | EDGAR |
| SC 13G/A | 2019-01-22 | JOHNSON & JOHNSON | Merus N.V. | - | - | EDGAR |